|Year : 2011 | Volume
| Issue : 1 | Page : 11-16
Clinico-epidemiological features of the hospitalized patients with 2009 pandemic influenza A (H1N1) virus infection in Saurashtra region, India (September, 2009 to February, 2010)
Rajesh K Chudasama, Umed V Patel, Pramod B Verma, Chikitsa D Amin, Dinkar Savaria, Rakesh Ninama, Nilesh Fichadiya
Department of Community Medicine, Government Medical College, Rajkot, Gujarat, India
|Date of Web Publication||31-Jan-2011|
Rajesh K Chudasama
Vandana Embroidary, Mato Shree Complex, Sardar Nagar Main Road, Rajkot - 360 001, Gujarat
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: The first case of 2009 pandemic influenza A (H1N1) virus infection in India was reported in May, 2009 and in Saurashtra region in August, 2009. We describe the clinico-epidemiological characteristics of patients who were hospitalized with 2009 influenza A (H1N1) infection in Saurashtra region. Materials and Methods: From September, 2009 to February, 2010, we observed 274 persons infected with 2009 influenza A (H1N1) virus who were admitted in different hospitals in Rajkot city. Real-time reverse-transcriptase-polymerase-chain-reaction (RT-PCR) testing was used to confirm infection; the clinico-epidemiological features of the disease were closely monitored. Results: Of 274 patients, median age was 29.5 years, and 51.5% were males. Only 1.1% patients had recent travel history to infected region. Median time of five days was observed from onset of illness to influenza A (H1N1) diagnosis, while median time of six days reported for hospital stay. All admitted patients received oseltamivir drug, but only 16.1% received it within two days of onset of illness. One fourth of admitted patients were expired. The most common symptoms were cough (96.7%), fever (92%), sore throat and shortness of breathing, and coexisting conditions including diabetes mellitus (9.9%), hypertension (8.8%), chronic pulmonary diseases (5.5%) and pregnancy (5.5%) (P<0.05). Pneumonia was reported in 93% patients with chest radiography. Conclusion: We have demonstrated that infection-related illness affects both children and adults with survival of 74% patients. The median time from onset of illness to virus detection with use of real-time RT-PCR is five days. Pregnancy is found as a significant (P<0.05) risk factor for severe disease.
Keywords: Epidemiologic information, H1N1 subtype, influenza A virus, reverse transcriptase polymerase chain reaction
|How to cite this article:|
Chudasama RK, Patel UV, Verma PB, Amin CD, Savaria D, Ninama R, Fichadiya N. Clinico-epidemiological features of the hospitalized patients with 2009 pandemic influenza A (H1N1) virus infection in Saurashtra region, India (September, 2009 to February, 2010). Lung India 2011;28:11-6
|How to cite this URL:|
Chudasama RK, Patel UV, Verma PB, Amin CD, Savaria D, Ninama R, Fichadiya N. Clinico-epidemiological features of the hospitalized patients with 2009 pandemic influenza A (H1N1) virus infection in Saurashtra region, India (September, 2009 to February, 2010). Lung India [serial online] 2011 [cited 2019 May 20];28:11-6. Available from: http://www.lungindia.com/text.asp?2011/28/1/11/76294
| Introduction|| |
Influenza A (H1N1) (earlier known as swine flu) is a new influenza virus causing illness in human beings. First detected in Mexico in April, 2009, it was originally referred as "swine flu" because many of the genes in this new virus were found in pigs in United States (US). Further on, it has been found that this new virus has gene segments from the swine, avian and human flu virus genes. The scientists call this a 'quadruple reassortant' virus and hence this new (novel) virus is christened "Influenza A (H1N1) virus". ,, The World Health Organization (WHO) raised the pandemic level from 5 to 6, the highest level after the documentation of human to human transmission of the virus in at least three countries in two of the six world regions defined by the WHO. ,
The first case of confirmed infection with the virus in India was documented in May, 2009,  but only few cases were reported up to August, 2009. After that large numbers of positive cases were reported throughout the India. From Gujarat state, first H1N1 positive confirmed case was reported in June 2009.  Saurashtra region is a western part of Gujarat state, and reported first case in August 2009.  All patients with confirmed infection were quarantined in isolation ward to prevent spread in the general population. This report summarizes the clinical and epidemiological characteristics of 274 confirmed cases of 2009 pandemic influenza A (H1N1) virus infection, hospitalized in various hospitals of Rajkot city of Saurashtra region from September, 2009 to February, 2010.
| Materials and Methods|| |
A total of 274 patients found to be positive and admitted in different hospitals of Rajkot from 1 st September, 2009 to 20 th February, 2010 were included for analysis.
Categorization of influenza A (H1N1) cases 
Ministry of Health and Family Welfare, Government of India had issued guidelines for categorization of influenza A (H1N1) cases during screening for home isolation, testing treatment, and hospitalization, [Table 1].
|Table 1 :Categorization of influenza A (H1N1) patients as per clinical features |
Click here to view
In current report, total 274 patients belonging to category C were tested confirmed, hospitalized, monitored and included in the analysis.
Clinical case /suspected case definition
A suspected case was defined as an influenza like illness (temperature≥37.5˚C and at least one of the following symptoms: sore throat, cough, rhinorrhea, or nasal congestion) and either a history of travel to a country where infection had been reported in the previous seven days or an epidemiologic link to a person with confirmed or suspected infection in the previous seven days. A confirmed case was defined by a positive result of a real-time reverse transcriptase polymerase chain reaction (RT-PCR) assay performed at a laboratory operated under the auspices of the state government.  A close contact was defined as a person who lived with or was exposed to the respiratory secretions or other bodily fluids of patients with suspected or confirmed influenza A (H1N1) infection.
Several types of data collected from the patients, including demographic, any coexisting conditions, regarding onset of illness and treatment, were taken. Data regarding hospitalization, whether intensive care needed, duration of antivirus drug, and disease outcome were collected from medical records and statistics departments of various hospitals.
Data collection and analysis were coordinated by the Community Medicine Department, P D U Medical College, Rajkot. All admitted patients' admission history and their medical records were assessed from swine flu ward for initial clinico-epidemiological details and from medical records and statistics departments after patient discharge/death from Civil Hospital and various private hospitals of Rajkot city. Line list number was given to every patient to avoid duplication at any time during study period. We made no assumptions regarding missing data; all proportions were calculated as percentages of the patients with available data. Approval by institutional review board was not required, because this infectious disease was covered under epidemic act and state health department  has implemented Epidemic Disease Control Act, 1897 from 18 th August, 2009 and issued a notification that it was in the interest of the public health to collect data on an emerging pathogen.
Laboratory confirmation of infection
The 2009 H1N1 virus was detected with the use of a real time RT-PCR assay in accordance with the protocol from the US centers for Disease Control and Prevention, as recommended by the WHO.  Two swabs from naso-pharynx and one from pharynx were collected from suspected patients and their contacts for detection of influenza A (H1N1) virus by real-time RT-PCR assay.
Continuous variables were summarized as means ( ± SD). For categorical variables, the percentages of patients in each category were calculated and appropriate statistical test (chi square test) was applied when required. We calculated descriptive statistics for all study variables. All data was entered in MS Excel, and analyzed by using Epi Info software (version 3.5.1) from CDC. 
| Results|| |
Demographic and clinical characteristics of patients
From 1 st September, 2009 to 20 th February, 2010, a total of 274 human cases of infection with 2009 H1N1 influenza A [Table 2] were diagnosed. Positive cases were reported mainly from Rajkot city (47.8%), followed by Rajkot district (26.6%), while 70 (25.6%) cases were from other districts of Saurashtra region namely, Junagadh, Kutch, Jamnagar, Porbandar, Amreli, Surendranagar and Bhavnagar.
|Table 2 :Baseline characteristics, disease history, and outcomes of 274 patients infected with 2009 pandemic influenza A (H1N1) virus in Saurashtra region |
Click here to view
Week wise distribution [Figure 1] of influenza A (H1N1) infected patients in Saurashtra region shows that number of cases increases gradually from first week of December, 2009 onwards. But from third week of December, 2009, sudden increase was seen with highest positive cases (42) reported in fourth week of December, 2009 which then remains at high level during January, 2010 followed by a gradual fall in number of positive cases in February, 2010.
The median age of 27 years was reported (range 4.5 months to 68 years) in positive cases. The median duration of diagnosis of infection was five days after onset of illness (1-20 days range). Of the 274 patients, majority of the patients reported with cough (97%) and fever (92%), followed by complaint of sore throat (54%) and shortness/difficulty in breathing (53%) [Table 3]. Totally, 91 (33.2%) cases had an underlying medical condition. Diabetes mellitus (DM) (9.9%) and hypertension (8.8%) either alone or together was mainly reported as the underlying condition, while chronic pulmonary diseases (asthma, chronic obstructive pulmonary disease (COPD), tuberculosis) were reported in 5.5% cases. Among reported female patients, 15 (5.5%) were pregnant with a range of 5 to 9 months of amenorrhea.
|Table 3 :Clinical features and coexisting conditions of 274 influenza A (H1N1) infected patients in Saurashtra region |
Click here to view
|Figure 1 :Week wise distribution of infected influenza A (H1N1) cases from September 2009 to February 2010 in Saurashtra region|
Click here to view
Laboratory and radiographic findings
Leukopenia was observed in 24.8% of 238 patients, and lymphopenia in 66.3% of adult patients and 21.7% of children [Table 4]. Among the admitted patients, 34.6% of 240 patients reported anemia, of which 9.6% had severe anemia (Hb <8 gm/dl) and 14.6% moderate anemia (Hb - 8-9.9 gm/dl). Thrombocytopenia was found in 22.9% of 214 patients tested. Chest X-ray was done in 227 (82.8%) admitted patients and among them pneumonia was found in 93% patients.
|Table 4 :Laboratory and radiographic findings on hospital admission in influenza A (H1N1) infected patients* |
Click here to view
The median time for hospital stay was six days for influenza A patients (H1N1). Duration of hospital stay of six days or more was observed in 58.8% patients. All the reported positive patients had received antiviral drug oseltamivir [Table 2]. Out of 274 positive patients, 16.1% received antiviral drug within two days of onset of illness. After hospital admission, 74% cases survived and discharged, while 26% cases were expired even after receiving treatment including antiviral drugs and life saving support. Among 71 expired patients, more than half of the patients (53.5%) were from productive age group 15-45 years. More than 40% patients were expired even after receiving complete course (five days) of antiviral drug oseltamivir.
Age fifteen years or less, presence of any coexisting condition, pregnancy, radiologically confirmed pneumonia were significantly associated (P<0.05) with severe influenza A (H1N1) patients who need either intensive care or died then among non severe cases, [Table 5].
|Table 5 :Characteristics of non severe and severe influenza A (H1N1) hospitalized patients |
Click here to view
| Discussion|| |
This cohort study identified 274 patients with confirmed 2009 influenza A (H1N1) belonging to category C,  who were hospitalized in various super specialty hospitals in Rajkot from September, 2009 to February, 2010. The median age of patients was 27 years. Significant association was found for age fifteen years or less and severe influenza A (H1N1) like other countries. ,, In China, majority (76.5%) of the infected patients have history of travel to infected origin countries, where one or more confirmed cases of 2009 pandemic influenza A (H1N1) virus infection had been found in the preceding seven days, while in our study, only 1.1% infected patients were reported to have history of travel to such areas. The median time of hospitalization from admission to discharge or death was six days (range <1 to 52 days). From onset of illness to diagnosis of infection and hospital admission, our study reported five days median time interval, more than in other countries, , with possible justification that patients from rural areas and small town areas were initially treated at local level by general practitioners, but with no or little improvement after initial treatment and later they were referred to higher center.
The majority of 2009 H1N1 viruses that have been tested at the CDC to date have been susceptible to two neuraminidase inhibitors, oseltamivir and zanamivir, and resistant to two adamantanes, amantadine and rimantadine. , Ministry of Health and Family Welfare, Government of India has recommended and supplied oseltamivir to the state governments for distribution in tertiary care centers and district hospitals in adequate quantity and was available in reported region also. Although the evidence of benefit from antiviral therapy is strongest when treatment is initiated within 48 h after the onset of illness, a study with oseltamivir in hospitalized patients reported reduction in mortality even after 48 h of onset of illness.  In present study area, all the influenza A (H1N1) infected patients received oseltamivir after hospital admission, but only 16.1% had received it within two days of onset of illness. Use of antiviral drug is beneficial, especially when initiated early, since patients who were admitted to ICU or died were less likely to have received such therapy within 48 h after the onset of symptoms,  while our study suggest 40% mortality even after complete course of oseltamivir therapy, possibly because of delayed referral and initiation of antiviral drug.
Week wise distribution shows that cases increases gradually from first week of December, and sudden increase was reported from third week (n=42) of December, which then remains at high level during January followed by gradual fall during February. The atmospheric temperature remains lowest in December and January, correlating to the increase in reported number of infected patients with influenza A (H1N1). It signifies the relationship between influenza virus and cold season, as maximum number of cases occurs during these months of winter season. ,,
Majority of the patients reported cough and fever similar to other countries. ,, Our study had a low prevalence (33.2%) of underlying medical conditions than in US (73%),  with a range of 44 to 84% as reported in other studies. ,, Diabetes mellitus (9.9%) and hypertension (8.8%) were the most common underlying conditions in the patients we studied, in contrast to asthma and COPD, as reported in US. , The 5.5% prevalence of pregnancy (P<0.05) in this cohort was higher than the expected prevalence in the general population (1%),  which was slightly low (7%) then reported in US.  Pregnancy as a risk factor is more strongly associated (P<0.05) with severe disease than non severe influenza. During periods of seasonal influenza and past pandemics, pregnant women have been at higher risk for influenza associated morbidity and mortality. ,, Significant number of patients with severe influenza A (H1N1) reported pneumonia (P<0.05) on chest radiography, received antiviral drugs and antibiotics. In the absence of accurate diagnostic methods, patients who are hospitalized with suspected influenza and lung infiltrates on chest radiography should be considered for treatment with both antibiotics and antiviral drugs. 
Limitations: The data was taken only from hospitalized patients. Patients belonging to category B, treated on outpatient basis and not being tested, were not included. All diagnostic testing was clinically driven, and other investigations were not obtained in a standardized fashion. Despite the use of a standardized data collection form, not all information was collected for all patients. The findings may be different during future waves, owing to the timely deployment of an effective vaccine, to viral mutation, and to resistance to antiviral drugs.
| Conclusion|| |
We have demonstrated that infection-related illness affects both children including infants and adults with survival of 74.1% patients. The median time from onset of illness to virus detection with use of real-time RT-PCR is five days. Pregnancy was found as a significant (P<0.05) risk factor for severe disease.
| Acknowledgment|| |
Authors are thankful to chief medical officer, Civil Hospital, Rajkot and other private hospitals for providing the necessary data. Authors are also thankful to nursing staff of swine flu ward and medical record department of Civil Hospital, Rajkot for helping in providing necessary records and information.
| References|| |
|1.||Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, et al. Novel swine origin influenza A (H1N1) virus investigation team: Emergence of a novel swine origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605-15. |
|2.||Ministry of Health and Family Welfare, Government of India. Factsheet Influenza A (H1N1). 2010. Available from: http://www.pib.nic.in/h1n1/factsheet.pdf [last accessed on 2010 Mar 06]. |
|3.||Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, et al. Antigenic and genetic characteristics of swine origin 2009 A (H1N1) influenza viruses circulating in humans. Science 2009;325:197-201. |
|4.||World Health Organization. Influenza A (H1N1) - update 14. Geneva. 2009. Available from: http://www.who.int/csr/don/2009_05_04a/en/index.html [last accessed on 2010 Feb 27]. |
|5.||Ministry of Health and Family Welfare, Government of India. Human swine influenza: A pandemic threat. Vol. 12. CD Alert; 2009. p. 1-8. |
|6.||Ministry of Health and Family welfare, Government of India. Situation update on H1N1. 2010. Available from: http://www.mohfw-h1n1.nic.in/documents/PDF/EpidemiologicalTrendsInIndia.pdf [last accessed on 2010 Feb 15]. |
|7.||The Times of India. First swine flu case surfaces in Gujarat. 18 th June, 2009. Available from: http://www.timesofindia.indiatimes.com/city/ahmedabad/First-swine-flu-case-surfaces-in-Gujarat/articleshow/4669250.cms [last accessed on 2010 Mar 01]. |
|8.||The Indian Express. Saurashtra`s first confirmed swine flu case detected. 19 th August, 2010. Available from: http://www.expressindia.com/latest-news/saurashtras-first-confirmed-swine-flu-case-detected-in-bhavnagar/503678/ [last accessed on 2010 Feb 27]. |
|9.||Ministry of Health and Family Welfare, Government of India. Guidelines on categorization of influenza A H1N1. May, 2009. Available from: http://www.mohfw-h1n1.nic.in/documents/pdf/3.Categorization%20of%20Influenza%20A%20H1N1%20cases%20screening.pdf [last accessed on 2010 Jan 15]. |
|10.||Ministry of Health and Family Welfare, Government of Gujarat. Epidemic Disease Control Act, 1897. Available from: http://www.expressindia.com/latest-news/epidemic-control-act-invoked-to-thwart-h1n1-scare-in-state/504144/ [last accessed on 2010 Mar 03]. |
|11.||World Health Organization. CDC protocol of realtime RTPCR for swine influenza A (H1N1). Geneva. April 28, 2009. Available from: http://www.who.int/csr/resources/publications/swineflu/CDCrealtimeRTPCRprotocol_20090428.pdf [last accessed on 2010 Jan 15]. |
|12.||Centers for Disease Control and Prevention. Epi Info version 3.5.1, 2008. Available from: http://www.cdc.gov/epiinfo/ [last accessed on 2008 Aug 15]. |
|13.||Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009;361:2507-17. |
|14.|| Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, et al. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA 2009;302:1872-9. |
|15.||Jain S, Schmitz AM, Louie J, Druckenmiller JK, Chugh R, Deutscher M, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009;361:1935-44. |
|16.||ANZIC Influenza Investigators, Webb SA, Pettilδ V, Seppelt I, Bellomo R, Bailey M, et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009;361:1925-34. |
|17.||Centers for Disease Control and Prevention. FluView: A weekly influenza surveillance report prepared by the Influenza Division. Atlanta. Available from: http://www.cdc.gov/flu/weekly/ [last accessed on 2010 Jan 21]. |
|18.||McGeer A, Green KA, Plevneshi A, Shigayeva A, Siddiqi N, Raboud J, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007;45:1568-75. |
|19.||Human infection with new influenza A (H1N1) virus: Clinical observations from a schoo-associated outbreak in Kobe, Japan, May 2009. Wkly Epidemiol Rec 2009;84:237-44. |
|20.||Human infection with new influenza A (H1N1) virus: Clinical observations from Mexico and other affected countries, May, 2009. Wkly Epidemiol Rec 2009;84:185-9. |
|21.||Walsh EE, Cox C, Falsey AR. Clinical features of influenza A infection in older hospitalized persons. J Am Geriatr Soc 2002;50:1498-503. |
|22.||Neuzil KM, Maynard C, Griffin MR, Heagerty P. Winter respiratory viruses and health care use: A population-based study in the northwest United States. Clin Infect Dis 2003;37:201-7. |
|23.||Ampofo K, Gesteland PH, Bender J, Mills M, Daly J, Samore M, et al. Epidemiology, complications, and cost of hospitalization in children with laboratory confirmed influenza infection. Pediatrics 2006;118:2409-17. |
|24.||Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009;374:451-8. |
|25.||Dodds L, McNeil SA, Fell DB, Allen VM, Coombs A, Scott J, et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ 2007;176:463-8. |
|26.||Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998;148:1094-102. |
|27.||Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, et al. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: Clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1003-32. |
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5]
|This article has been cited by|
||Global Burden of Influenza as a Cause of Cardiopulmonary Morbidity and Mortality
| ||William A. Fischer,Michelle Gong,Satish Bhagwanjee,Jonathan Sevransky |
| ||Global Heart. 2014; 9(3): 325 |
|[Pubmed] | [DOI]|
||Impact of H1N1 on socially disadvantaged populations: summary of a systematic review
| ||Andrea C. Tricco,Erin Lillie,Charlene Soobiah,Laure Perrier,Sharon E. Straus |
| ||Influenza and Other Respiratory Viruses. 2013; 7: 54 |
|[Pubmed] | [DOI]|
||Impact of H1N1 on socially disadvantaged populations: Systematic review
| ||Tricco, A.C. and Lillie, E. and Soobiah, C. and Perrier, L. and Straus, S.E. |
| ||PLoS ONE. 2012; 7(6) |
||Pandemic influenza - Indian experience
| ||Suri, J.C., Sen, M.K. |
| ||Lung India. 2011; 28(1): 2-4 |